Status:
UNKNOWN
Effect of Real-time Continuous Glucose Monitoring System in Overweight or Obese Adults With Prediabetes
Lead Sponsor:
Pusan National University Hospital
Conditions:
Continuous Glucose Monitoring
Prediabetic State
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In Korea, 5 million adults aged 30 years or older have diabetes. The development and expansion of Korea's economy and society, has led to dramatic chances in people's lifestyle and diet habits, and an...
Detailed Description
Optimising patient adherence to prescribed lifestyle interventions to achieve improved blood glucose control remains a challenge. Combined use of real-time continuous glucose monitoring (RT-CGM) syste...
Eligibility Criteria
Inclusion
- ≥ BMI 23 kg/m2
- impaired fasting glucose (fasting glucose 100 to 125 mg/dL) or impaired glucose tolerance (2-h plasma glucose during oral glucose tolerance test (OGTT) 140 - 199 mg/dl) or HbA1c 5.7% to 6.4%
Exclusion
- type 1 diabetes or type 2 diabetes or undergoing treatment for diabetes
- clinical history including malignancy
- fast history of cardiovascular disease (e.g. myocardial infarction, stroke), surgery, and trauma which may affect blood glucose within last 6 months
- taking medication (e.g. glucocorticoid, antipsychotics, anticholinergic drug etc.) which affect blood glucose
- acute infection within last 1 month
- pregnancy
Key Trial Info
Start Date :
December 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04099550
Start Date
December 6 2019
End Date
December 1 2021
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeong Mi Kim
Busan, South Korea, 49241